nafamostat has been researched along with aspirin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Asano, Y; Kusano, E; Masunaga, Y; Matsuo, M; Matsuo, T; Miyata, Y; Muto, S; Nakazawa, E; Takahashi, H; Tamba, K; Yanagiba, S | 1 |
2 other study(ies) available for nafamostat and aspirin
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Combined treatment with nafamostat mesilate and aspirin prevents heparin-induced thrombocytopenia in a hemodialysis patient.
Topics: Adult; Anticoagulants; Aspirin; Benzamidines; Extracorporeal Circulation; Guanidines; Heparin; Humans; Male; Platelet Aggregation Inhibitors; Renal Dialysis; Thrombocytopenia | 2003 |